November 22nd, 2026Five Under 5: Top Oncology Videos for the Week of 11/20The top 5 OncLive TV videos of the week cover insights in NSCLC, HER2+ gastroesophageal cancer, low-grade glioma, HR+ breast cancer, and CML.Read more
November 21st, 2026The OncFive: Top Oncology Articles for the Week of 11/15The FDA approved giredestrant plus everolimus in ESR1-mutated breast cancer and neladalkib in ALK+ NSCLC, issued a CRL to ivonescimab, and more.Read more
November 20th, 2026Daraxonrasib Plus Gemcitabine/Nab-Paclitaxel Generates Durable Responses in First-Line Metastatic PDACDaraxonrasib plus gemcitabine/nab-paclitaxel yielded a 60.7% ORR and 12.8-month median PFS in first-line metastatic pancreatic adenocarcinoma.Read more
November 20th, 2026TroFuse-015 Meets Primary OS End Point With Sac-TMT in Third-Line or Later Gastroesophageal AdenocarcinomaSac-TMT improved OS vs treatment of physician’s choice in pretreated gastroesophageal adenocarcinoma, but TroFuse-015 missed its PFS secondary end point.Read more
November 20th, 2026OncLive Weekly News Quiz (11/20/2026): Did You Miss Crucial Lung Cancer, PCNSL, Gastroesophageal Cancer, and AML Updates?Did you catch all of this week's top oncology news? Test your knowledge with OncLive's Weekly News Quiz.Read more
November 19th, 2026FDA Grants Priority Review to Sonesitatug Vedotin in CLDN18.2+ Gastroesophageal CancerThe FDA granted priority review to sonesitatug vedotin for previously treated CLDN18.2-positive advanced gastroesophageal cancers.Read more
November 19th, 2026Revisit Every OncLive On Air Episode From October 2026In case you missed any, read a recap of the episodes of OncLive On Air that aired in October 2026. Read more
November 17th, 2026Long-Term SANO Data Reinforce Active Surveillance as an Option in Esophageal Cancer Sanjiv Gangaram-Panday, MD, PhD, discusses 5-year SANO outcomes, distant dissemination, and next steps for active surveillance in esophageal cancer.Read more